Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.
about
Developing drugs targeting transition metal homeostasis.Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosisA Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin ResistanceCopper Signaling in the Brain and Beyond.Copper accumulation in senescent cells: Interplay between copper transporters and impaired autophagy.Gendermetrics of cancer research: results from a global analysis on prostate cancer.
P2860
Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Copper as a target for prostat ...... systemic copper distribution.
@en
Copper as a target for prostat ...... systemic copper distribution.
@nl
type
label
Copper as a target for prostat ...... systemic copper distribution.
@en
Copper as a target for prostat ...... systemic copper distribution.
@nl
prefLabel
Copper as a target for prostat ...... systemic copper distribution.
@en
Copper as a target for prostat ...... systemic copper distribution.
@nl
P2093
P2860
P50
P356
P1433
P1476
Copper as a target for prostat ...... g systemic copper distribution
@en
P2093
Irene Volitakis
Michael A Cater
Peter M Meggyesy
Roxana M Llanos
Sharnel A S Clatworthy
P2860
P304
37064-37080
P356
10.18632/ONCOTARGET.9245
P407
P577
2016-06-01T00:00:00Z